Is Now An Opportune Moment To Examine Synektik Spólka Akcyjna (WSE:SNT)?
Jan 21
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies47
- 7D1.0%
- 3M-3.1%
- 1Y2.0%
- YTD-0.6%
The Healthcare is pretty flat in the last 7 days, but Synektik Spólka Akcyjna has stood out, gaining 5.9%. Furthermore, the industry has been flat for the past year as well. Looking forward, earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | zł15.2b | zł16.7b | zł123.0m | 23.5x | 123.2x | 0.9x |
| Thu, 19 Dec 2024 | zł14.7b | zł16.7b | zł122.9m | 24.2x | 119.9x | 0.9x |
| Sat, 16 Nov 2024 | zł14.6b | zł16.4b | zł53.4m | 21.4x | 273.6x | 0.9x |
| Mon, 14 Oct 2024 | zł15.8b | zł16.4b | zł83.0m | 24x | 190.4x | 1x |
| Wed, 11 Sep 2024 | zł15.3b | zł16.4b | zł167.9m | 28.3x | 91x | 0.9x |
| Fri, 09 Aug 2024 | zł14.7b | zł16.2b | zł137.0m | 28.6x | 107.4x | 0.9x |
| Sun, 07 Jul 2024 | zł14.6b | zł16.2b | zł134.2m | 26.2x | 108.9x | 0.9x |
| Tue, 04 Jun 2024 | zł14.8b | zł16.1b | zł74.7m | 22.3x | 198.7x | 0.9x |
| Thu, 02 May 2024 | zł14.7b | zł16.0b | -zł129,953,749.00 | 38.7x | -113.1x | 0.9x |
| Sat, 30 Mar 2024 | zł15.0b | zł14.9b | -zł295,894,549.00 | 45x | -50.7x | 1x |
| Mon, 26 Feb 2024 | zł14.9b | zł16.0b | -zł199,514,549.00 | 41.1x | -74.6x | 0.9x |
| Wed, 24 Jan 2024 | zł14.9b | zł15.9b | -zł247,198,884.00 | 34.5x | -60.1x | 0.9x |
| Fri, 22 Dec 2023 | zł14.8b | zł15.9b | -zł245,263,080.00 | 30.6x | -60.2x | 0.9x |
| Sun, 19 Nov 2023 | zł13.6b | zł15.9b | zł158.3m | 27x | 86.1x | 0.9x |
| Tue, 17 Oct 2023 | zł13.7b | zł15.7b | zł114.5m | 31.1x | 119.2x | 0.9x |
| Thu, 14 Sep 2023 | zł14.1b | zł15.7b | zł70.4m | 20.2x | 201x | 0.9x |
| Sat, 12 Aug 2023 | zł14.4b | zł15.4b | zł114.4m | 25.4x | 125.9x | 0.9x |
| Mon, 10 Jul 2023 | zł14.2b | zł15.4b | zł121.8m | 24.8x | 116.5x | 0.9x |
| Wed, 07 Jun 2023 | zł14.0b | zł15.5b | zł192.3m | 24.1x | 72.9x | 0.9x |
| Fri, 05 May 2023 | zł13.6b | zł15.4b | zł423.1m | 24.7x | 32x | 0.9x |
| Sun, 02 Apr 2023 | zł13.0b | zł15.4b | zł248.1m | 25.3x | 52.5x | 0.8x |
| Tue, 28 Feb 2023 | zł13.4b | zł15.1b | zł259.2m | 29.3x | 51.9x | 0.9x |
| Thu, 26 Jan 2023 | zł13.5b | zł15.0b | zł237.9m | 26.9x | 56.6x | 0.9x |
| Sat, 24 Dec 2022 | zł12.2b | zł15.0b | zł230.0m | 25.1x | 53.1x | 0.8x |
| Mon, 21 Nov 2022 | zł12.3b | zł15.1b | -zł135,505,786.00 | 19.6x | -91.1x | 0.8x |
| Wed, 19 Oct 2022 | zł11.6b | zł14.8b | -zł130,100,544.00 | 23.1x | -89.4x | 0.8x |
| Fri, 16 Sep 2022 | zł12.3b | zł15.0b | zł235.8m | 27.5x | 52x | 0.8x |
| Sun, 14 Aug 2022 | zł13.3b | zł14.6b | zł272.7m | 22.6x | 48.7x | 0.9x |
| Tue, 12 Jul 2022 | zł12.7b | zł14.8b | zł265.8m | 20.7x | 47.9x | 0.9x |
| Thu, 09 Jun 2022 | zł12.7b | zł14.7b | zł271.3m | 18.8x | 46.7x | 0.9x |
| Sat, 07 May 2022 | zł13.0b | zł14.9b | zł850.7m | 24.5x | 15.2x | 0.9x |
| Mon, 04 Apr 2022 | zł15.1b | zł14.9b | zł904.9m | 24.7x | 16.7x | 1x |
| Wed, 02 Mar 2022 | zł14.3b | zł14.8b | zł906.6m | 20.7x | 15.7x | 1x |
| Fri, 28 Jan 2022 | zł15.6b | zł14.8b | zł930.7m | 22.4x | 16.8x | 1.1x |
Price to Earnings Ratio
16.8x
Current Industry PE
- Investors are optimistic on the Polish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 123x which is higher than its 3-year average PE of 56.1x.
- The industry is trading close to its 3-year average PS ratio of 0.92x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 49% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | 3.85% | |
| Healthcare | 1.00% | |
| Healthtech | 10.43% | |
| Healthcare Services | 2.67% | |
| Biotech | 0.79% | |
| Pharma | 0.15% | |
| Medical Equipment | -2.15% | |
| Life Sciences | -9.84% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 30.7x.
- Analysts are expecting annual earnings growth of 14.4%, which is lower than the prior year's growth of 61.4% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 31% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Pharma industry is expected to see its earnings decline by 30% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SNT Synektik Spólka Akcyjna | zł233.00 | 10.4% +zł187.6m | 170.3% | PE23.5x | |
| VOX Voxel | zł137.00 | 12.3% +zł157.5m | 67.5% | PE16.2x | |
| ENE Centrum Medyczne ENEL-MED | zł21.00 | 5.0% +zł28.3m | -5.4% | PE85.1x | |
| BIO BIOTON | zł3.52 | 10.2% +zł27.9m | 0.9% | PS1.7x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł46.90 | 7.6% +zł15.4m | -52.1% | PS11.3x |
